ANL
Adlai Nortye Ltd. American Depositary SharesNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$767.62M
P/E Ratio
—
EPS
$-1.11
Beta
1.29
52W High
$17.25
52W Low
$0.88
50-Day MA
$11.56
200-Day MA
$5.27
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Adlai Nortye Ltd. American Depositary Shares
Adlai Nortye Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of cancer therapies in the United States and Mainland China. The company is headquartered in Grand Cayman, the Cayman Islands.
Fundamentals
| Revenue (TTM) | $5.00M |
| Gross Profit (TTM) | $5.00M |
| EBITDA | $-34.94M |
| Operating Margin | -330.50% |
| Return on Equity | -414.00% |
| Return on Assets | -42.20% |
| Revenue/Share (TTM) | $0.16 |
| Book Value | $-0.21 |
| Price-to-Book | 82.76 |
| Price-to-Sales (TTM) | 153.52 |
| EV/Revenue | 153.84 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 178.10% |
| Shares Outstanding | $58.73M |
| Float | $56.32M |
| % Insiders | 5.66% |
| % Institutions | 24.53% |
Historical Volatility
HV 10-Day
103.41%
HV 20-Day
109.76%
HV 30-Day
141.71%
HV 60-Day
126.90%
HV Rank
—
Volatility is currently contracting
Analyst Ratings
Consensus ($27.75 target)
3
BuyMore HEALTHCARE Stocks
Data last updated: 5/25/2026